Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-23-016643
Filing Date
2023-05-09
Accepted
2023-05-09 08:55:29
Documents
76
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q mrsn-20230331.htm   iXBRL 10-Q 1401620
2 EX-10.1 exhibit101oxford-svbxmersa.htm EX-10.1 41839
3 EX-10.2 exhibit102merck2014license.htm EX-10.2 808035
4 EX-10.3 exhibit103merck2014amendme.htm EX-10.3 47285
5 EX-10.4 exhibit104merck2014amendme.htm EX-10.4 49322
6 EX-10.5 exhibit105merck2014amendme.htm EX-10.5 62201
7 EX-10.6 exhibit1062015receptalicen.htm EX-10.6 405787
8 EX-10.7 exhibit1072015receptalicra.htm EX-10.7 30239
9 EX-31.1 exhibit31110-qfy2023q1.htm EX-31.1 11201
10 EX-31.2 exhibit31210-qfy2023q1.htm EX-31.2 11166
11 EX-32.1 exhibit32110-qfy2023q1.htm EX-32.1 5793
17 image_4.jpg GRAPHIC 5140
  Complete submission text file 0001628280-23-016643.txt   7525998

Data Files

Seq Description Document Type Size
12 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mrsn-20230331.xsd EX-101.SCH 39995
13 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mrsn-20230331_cal.xml EX-101.CAL 44276
14 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mrsn-20230331_def.xml EX-101.DEF 192523
15 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mrsn-20230331_lab.xml EX-101.LAB 478965
16 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mrsn-20230331_pre.xml EX-101.PRE 331818
70 EXTRACTED XBRL INSTANCE DOCUMENT mrsn-20230331_htm.xml XML 832286
Mailing Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139 617-498-0020
Mersana Therapeutics, Inc. (Filer) CIK: 0001442836 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38129 | Film No.: 23900180
SIC: 2834 Pharmaceutical Preparations